• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

    7/14/24 1:22:45 PM ET
    $APGE
    $CRNX
    $DYN
    $JOBY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $APGE alert in real time by email

    These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

    1. QuantumScape Corporation (NYSE:QS) stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen's battery company PowerCo to industrialize solid-state batteries.
    2. Lantheus Holdings, Inc. (NASDAQ:LNTH) shares rocketed 55.93% following a CMS proposal to improve payment for Specialized Diagnostic Radiopharmaceuticals.
    3. Sunrun Inc. (NASDAQ:RUN) shares increased 37.59%. as shares of companies within the broader industrial sector gained following recent CPI data.
    4. Kymera Therapeutics, Inc. (NASDAQ:KYMR) shares rose 37.38% after the company announced its intention to expand Phase 2 trials for Hidradenitis Suppurativa and Atopic Dermatitis to more rapidly progress towards pivotal studies following an interim review of safety and efficacy.
    5. Apogee Therapeutics, Inc. (NASDAQ:APGE) shares upped 35.68%.
    6. Joby Aviation, Inc. (NYSE:JOBY) stock was up 29.10% after the company announced it successfully flew a hydrogen-electric air taxi demonstrator 523 miles, with water as the only by-product.
    7. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) shares grew 21.18%  after JP Morgan raised its price target from $47 to $54.
    8. Dyne Therapeutics, Inc. (NASDAQ:DYN) stock grew 19.75% after JP Morgan maintained an Overweight rating on the stock and raised its price target from $39 to $43.
    9. Summit Therapeutics Inc (NASDAQ:SMMT) stock gained 17.24% in the last week.
    10. Plug Power Inc (NASDAQ:PLUG) stock upped 16.51% as EV-related stocks gained following recent CPI Data. The Department of Energy also announced a $1.7 billion to convert 11 shuttered or at-risk auto facilities to manufacture electric vehicles and their supply chain.
    11. XPeng Inc. (NYSE:XPEV) stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.

    Also Read

    • Rivian Automotive & Baidu Are Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 7-July 13): Are The Others In Your Portfolio?
    • Netflix, Delta Air Lines And HubSpot Are Among Top 10 Large Stocks That Performed Worst This Week (July 7-July 13): Are The Others In Your Portfolio?

    Photo Courtesy of QuantumScape

    Get the next $APGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APGE
    $CRNX
    $DYN
    $JOBY

    CompanyDatePrice TargetRatingAnalyst
    Kymera Therapeutics Inc.
    $KYMR
    1/28/2026$133.00Overweight
    Barclays
    Apogee Therapeutics Inc.
    $APGE
    1/22/2026$83.00Outperform → Sector Perform
    RBC Capital Mkts
    Sunrun Inc.
    $RUN
    1/13/2026Mkt Perform
    Raymond James
    Crinetics Pharmaceuticals Inc.
    $CRNX
    1/12/2026$67.00Neutral → Buy
    Goldman
    Plug Power Inc.
    $PLUG
    1/9/2026$2.00Buy → Hold
    TD Cowen
    Apogee Therapeutics Inc.
    $APGE
    1/7/2026Peer Perform
    Wolfe Research
    Kymera Therapeutics Inc.
    $KYMR
    1/6/2026Outperform → Peer Perform
    Wolfe Research
    Apogee Therapeutics Inc.
    $APGE
    12/17/2025$95.00Overweight
    Stephens
    More analyst ratings

    $APGE
    $CRNX
    $DYN
    $JOBY
    SEC Filings

    View All

    SEC Form ABS-15G filed by Sunrun Inc.

    ABS-15G - Sunrun Inc. (0001469367) (Filer)

    2/13/26 1:09:42 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Plug Power Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - PLUG POWER INC (0001093691) (Filer)

    2/13/26 10:40:14 AM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Lantheus Holdings Inc.

    SCHEDULE 13G/A - Lantheus Holdings, Inc. (0001521036) (Subject)

    2/12/26 12:50:04 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $APGE
    $CRNX
    $DYN
    $JOBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on Kymera Therapeutics with a new price target

    Barclays resumed coverage of Kymera Therapeutics with a rating of Overweight and set a new price target of $133.00

    1/28/26 7:18:07 AM ET
    $KYMR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Apogee Therapeutics downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Apogee Therapeutics from Outperform to Sector Perform and set a new price target of $83.00

    1/22/26 8:24:52 AM ET
    $APGE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Raymond James initiated coverage on Sunrun

    Raymond James initiated coverage of Sunrun with a rating of Mkt Perform

    1/13/26 9:17:53 AM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $APGE
    $CRNX
    $DYN
    $JOBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Michael N. Jr. bought $14,564 worth of shares (1,100 units at $13.24) (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    1/2/26 4:43:46 PM ET
    $JOBY
    Aerospace
    Industrials

    Officer Crespo Jose Luis bought $87,282 worth of shares (37,300 units at $2.34), increasing direct ownership by 14% to 307,332 units (SEC Form 4)

    4 - PLUG POWER INC (0001093691) (Issuer)

    12/17/25 9:06:21 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Director Baker Bros. Advisors Lp bought $172,499,918 worth of shares (2,005,813 units at $86.00) (SEC Form 4)

    4 - Kymera Therapeutics, Inc. (0001815442) (Issuer)

    12/11/25 4:19:37 PM ET
    $KYMR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APGE
    $CRNX
    $DYN
    $JOBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wheels Up to Present at Barclays Industrial Select Conference

    ATLANTA, Feb. 12, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP), one of the world's leading providers of on-demand private aviation, today announced that the company's Chief Executive Officer, George Mattson, will present in person at the Barclays Industrial Select Conference in Miami, FL on Thursday, February 19, 2026 at 10:25am ET. A live webcast of this event will be available at investors.wheelsup.com and online replay will be available shortly after the webcast is complete. About Wheels Up Wheels Up is a leading global provider of on-demand private aviation wit

    2/12/26 8:30:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

    BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time. A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least

    2/12/26 8:00:00 AM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $APGE
    $CRNX
    $DYN
    $JOBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fenster Edward Harris gifted 25,000 shares, exercised 250,600 shares at a strike of $5.08 and sold $3,269,222 worth of shares (163,844 units at $19.95), increasing direct ownership by 4% to 1,553,895 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    2/12/26 5:21:57 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    Officer Dehoff Kate converted options into 2,958 shares and sold $172,241 worth of shares (17,311 units at $9.95), decreasing direct ownership by 9% to 149,369 units (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    2/11/26 6:28:42 PM ET
    $JOBY
    Aerospace
    Industrials

    Chief Policy Officer Bowles Gregory converted options into 2,606 shares and sold $8,609 worth of shares (816 units at $10.55), increasing direct ownership by 1% to 164,464 units (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    2/11/26 6:28:36 PM ET
    $JOBY
    Aerospace
    Industrials

    $APGE
    $CRNX
    $DYN
    $JOBY
    Leadership Updates

    Live Leadership Updates

    View All

    Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors

    BOSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors, effective January 1, 2026. Dr. Incerti is a highly accomplished executive with a strong background in medicine and over 35 years of strategic experience in the biopharmaceutical industry. "Carlo's appointment comes at a pivotal moment for Sparrow as we are looking ahead to pivotal trials of clofutriben for type 2 diabetes and seeking to expand development into other cardiometabolic indications," said Robert Jacks, Sparrow President and Chief Executive Officer. "Carlo is respected globally for

    2/2/26 8:30:00 AM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    QuantumScape Welcomes Tech Industry Veteran Geoff Ribar to Board of Directors

    QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Geoff Ribar to its board of directors. Ribar brings deep expertise and extensive leadership experience in the technology industry, with decades serving as CFO for companies across the sector. Ribar was Chief Financial Officer at Cadence Design Systems from 2010 to 2017 and previously served as CFO at Telegent Systems, Matrix Semiconductor and NVIDIA Corporation, among others. He was formerly Vice President and corporate controller at Advanced Micro Devices (AMD). He also serves on the board of directors at Acacia Research Corporation, Ev

    1/30/26 6:55:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    Plug Power Calls on Stockholders to Act Now and Vote in Favor of Proposals at January 29, 2026 Special Meeting

    SLINGERLANDS, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, encourages stockholders to vote their shares ahead of the Company's Special Meeting of Stockholders (the "Special Meeting") scheduled for January 29, 2026. The Special Meeting includes proposals that are critical to supporting the Company's ongoing operations, financial flexibility and long-term growth strategy. The Board of Directors urges stockholders of record as of December 12, 2025 (the "Record Date") to vote their shares in favor of all proposals presented at the Special Meeting. This Special Meeting follows the Company's

    1/27/26 2:14:23 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    $APGE
    $CRNX
    $DYN
    $JOBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Lantheus Holdings Inc.

    SC 13G - Lantheus Holdings, Inc. (0001521036) (Subject)

    11/14/24 8:21:14 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 7:55:29 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 5:46:54 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APGE
    $CRNX
    $DYN
    $JOBY
    Financials

    Live finance-specific insights

    View All

    Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

    BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025. To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time. A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least

    2/12/26 8:00:00 AM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Joby Aviation to Report Fourth Quarter and Full Year 2025 Financial Results

    Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced that it expects to release its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026, and to host a webcast at 5:00 pm ET on the same day. The webcast will be publicly available in the Upcoming Events section of the company website, www.jobyaviation.com. If unable to attend the webcast, to listen by phone, please dial 1-877-407-9719 or 1-201-378-4906. A replay of the webcast will be available on the company website following the event. This press release features multimedia. View the full release here: https://www.busine

    2/11/26 4:15:00 PM ET
    $JOBY
    Aerospace
    Industrials

    Wheels Up Announces Date of Fourth Quarter 2025 Earnings Release

    ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that it will release its fourth quarter 2025 financial results on Thursday, February 19, 2026. Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading global provider of on-demand private aviation with a large, diverse fleet and a network of safety-vetted charter operators, all committed to safety and service. Customers access charter and membership programs and premium commercial travel benefits th

    2/5/26 8:00:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary